Joe Mullings, chairman and CEO of The Mullings Group, said the FDA’s AI framework couldn’t come at a better time, since AI algorithms are always changing.

“AI uses algorithms, and algorithms are still a black art of sorts, so having a gatekeeper like the FDA is critical,” he told Lifewire in a phone interview. “[AI] used in the proper ways will impact healthcare at a dramatic scale that we’ve never seen before.”